Human Anti-Idiotype Antibodies in Cancer Patients: Is the Modulation of the Immune Response Beneficial for the Patient?

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.81.1.216
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Anti-Idiotype Antibodies in Cancer Treatment

Frontiers Research Topics
2013English

The Antibodies Involved in the Human Immune Response to Leptospiral Infection

Journal of Medical Microbiology
MedicineMicrobiology
1978English

Production of Auto-Anti-Idiotypic Antibody During the Normal Immune Response: Changes in the Auto-Anti-Idiotypic Antibody Response and the Idiotype Repertoire Associated With Aging.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1980English

A Possible Role for Idiotype/Anti-Idiotype B–T Cell Interactions in Maintaining Immune Memory

Frontiers in Immunology
AllergyImmunology
2017English

In-Vivo Modulation of the Immune Response by Human Fetal Kidney • 1796

Pediatric Research
Child HealthPediatricsPerinatology
1998English

Functional Analysis of the Anti-Adalimumab Response Using Patient-Derived Monoclonal Antibodies

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2014English

Is Immune Nutrition the Holy Grail for Cancer Patients?

2000English

Characterization of Anti-Anti-Idiotypic Antibodies That Bind Antigen and an Anti-Idiotype

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1997English

HDAC Inhibitor, CG-745, Enhances the Anti-Cancer Effect of Anti-Pd-1 Immune Checkpoint Inhibitor by Modulation of the Immune Microenvironment

Journal of Cancer
Oncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy